Back to Search
CAROL FABIAN, M.D.
M.D.
Medical Oncology Physician
NPI: 1215034780IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
04-16438(KS)
Education
UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Class of 1972
Research & Publications (20)
Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
PMID 18006909·Cancer Epidemiol Biomarkers Prev·2007
8-other
Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
PMID 17221152·Breast Cancer Res Treat·2007
3-trial
The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer.
PMID 17892469·Int J Clin Pract·2007
6-review
Mammographic density: use in risk assessment and as a biomarker in prevention trials.
PMID 16988158·J Nutr·2006
8-other
Selective estrogen-receptor modulators for primary prevention of breast cancer.
PMID 15755972·J Clin Oncol·2005
6-review
Breast cancer chemoprevention: current challenges and a look toward the future.
PMID 12123535·Clin Breast Cancer·2002
6-review
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer.
PMID 19655244·Breast Cancer Res Treat·2010
8-other
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
PMID 19349550·J Clin Oncol·2009
3-trial
Surrogate response biomarkers in prevention research: do they point the way or lead us astray?
PMID 19597020·J Clin Oncol·2009
8-other
Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.
PMID 19125322·Breast Cancer Res Treat·2009
2-rct
Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.
PMID 19139004·Cancer Prev Res (Phila)·2008
7-preclinical
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.
PMID 18853415·Cancer·2008
8-other
Low-dose tamoxifen for combination hormone replacement therapy users.
PMID 17709795·J Clin Oncol·2007
8-other
Karyometry of breast epithelial cells acquired by random periareolar fine needle aspiration in women at high risk for breast cancer.
PMID 17484269·Anal Quant Cytol Histol·2007
8-other
[Anemia prevalence and associated factors among adult women in São Leopoldo, Rio Grande do Sul, Brazil].
PMID 17486241·Cad Saude Publica·2007
8-other
Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
PMID 17507634·Cancer Epidemiol Biomarkers Prev·2007
8-other
Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
PMID 17537236·Breast Cancer Res·2007
8-other
Workshop on imaging science development for cancer prevention and preemption.
PMID 17655039·Cancer Biomark·2007
8-other
Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF.
PMID 18006786·Clin Cancer Res·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2330 SHAWNEE MISSION PKWY, SUITE 210, MAIL STOP 5003
WESTWOOD, KS 66205 - Phone
- (913) 588-6029
Quick Facts
- NPI
- 1215034780
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 54
- Publications
- 20
Are you this provider?
Claim Your Profile